C12N 2770/24043
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2770/24043 (Viral genome or elements thereof as genetic vector) appears on 3 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 6
- Assignees
- 6
- Inventors
- 13
- Latest grant
- 15 Mar 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Next generation mrna vaccines20 Mar 2025US 2025/0090648 A1FuTr Bio Ltda.
- E protein-mutated west nile virus used as liveattenuated vaccine and oncolytic drug for cancer therapy17 Oct 2024US 2024/0342265 A1SICHUAN ANCOCARE BIOPHARMACEUTICAL, Ltd.
- Methods of treating cancer5 Sep 2019US 2019/0269711 A1Ascend Biopharmaceuticals Ltd
- Citrus plants resistant to citrus huanglongbing (ex greening) caused by candidatus liberibacter asiaticus (las) and bacterial canker caused by (xanthomonas axonopodis pv. citri) (xac)5 Mar 2015US 2015/0067918 A1Southern Gardens Citrus
- Recombinant vaccine against West Nile Virus10 Feb 2005US 2005/0031641 A1
Most cited
By later US patents